Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, October 15, 2026

Back to today

Is The Market Turning The Page?

CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.

CRWV $34B
WHAT ARE WE DOING? “Contrarians At The Gate” 51 clicks

From X

@KEDM_COM 2 clicks

KEDM.com on X

Right Tail @JeremyKokemor bought $HCA at about 12x earnings on a local-density argument: hospitals compete neighborhood by neighborhood, and HCA holds #1 or #2 share — averaging 25-30% of each market in about 80% of its markets, primarily in Sunbelt states. Outpatient access points — 14 per hospital, heading toward 20 — feed the hospitals, and about 75% of admissions arrive through the ER. Margins held in the high teens through 2009, and half the shares have been retired since the 2011 re-IPO. Historically, HCA has compounded revenue at roughly 7% annually and EPS closer to 17%; Right Tail models mid-single-digit revenue growth and 10-15% EPS growth.
@Fierce__beast 1 click

Fierce_beast on X

Here's the J-curve stock shape -- many examples of software stocks and high growth stocks, sometimes even large mature companies that release a new product. $MPWR was shaping up for this in November 2024 (I wrote about this and went long) when it dropped a lot after they "lost $NVDA" marketshare, but of course their custom AI accelerator business was growing something like 100% a year, and it was only a matter of time before it showed up in the earnings. It subsequently re-rated after troughing at 35x and had significant earnings growth. Today it goes for 35x again. Will there be another big bump in a few years, maybe robotics?
@Fierce__beast 1 click

Fierce_beast on X

This is the shape of many AI related beneficiaries that I think is the most likely path, a few bumps along the way of course, but more or less the path: $AVGO is an interesting example it has expected EPS growth that looks almost exactly like this, but it doesn't trade for 67.5x, it trades for 20x, which seems to imply that earnings growth rate expectations will pretty dramatically slow down within the next 12-24 months. This doesn't seem likely to me. Of course when I say expected EPS these views are extrapolations of near-term trends and discussions about long-term demand, but all i am making a point about is that if $AVGO's estimates actually materialize roughly like the consensus estimates think, the stock should probably be at least 100% higher.

Investor Letters

All letters

Constellation: Stars Aligning?

Constellation Brands trades near $127 at roughly 11x next-twelve-month EV/EBIT, with recent business results offsetting concerns over…

STZ $22B
TSOH Investment Research 27 clicks

TSMC Q3 FY12/26 Earnings Review

TSMC reported excellent Q3 results, guided Q4 revenue growth higher and saw its shares slip despite strong AI-driven earnings momentum.

TSM $2.3T
Cestrian Capital Research 9 clicks

My 2028 numbers

ASML’s €11.7 billion quarter benefited from €3.3 billion in installed-base sales and operating leverage, while the MATCH Act threatens…

ASML $631B
Best Anchor Stocks 26 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $17B
Latticework by MOI Global 15 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $17B
Latticework by MOI Global 13 clicks

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 108

YouTube 4

Blogs 17

Seeking Alpha 52 of 238

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

89 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.